In each subgroup, most carcinomas showed expression of Nectin-4, including 100% (14/14) of the SCC cohort, 91% (20/22) of the AC/UrC cohort, and 82% (69/84) of the Sq-BLCA cohort. This evidence concerns the gene NECTIN4 and carcinoma.